Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 201

1.

Cholesterol and cognition in schizophrenia: a double-blind study of patients randomized to clozapine, olanzapine and haloperidol.

Krakowski M, Czobor P.

Schizophr Res. 2011 Aug;130(1-3):27-33. doi: 10.1016/j.schres.2011.04.005. Epub 2011 May 6.

PMID:
21549568
[PubMed - indexed for MEDLINE]
2.

Atypical antipsychotics, neurocognitive deficits, and aggression in schizophrenic patients.

Krakowski MI, Czobor P, Nolan KA.

J Clin Psychopharmacol. 2008 Oct;28(5):485-93. doi: 10.1097/JCP.0b013e3181855cd6.

PMID:
18794642
[PubMed - indexed for MEDLINE]
3.

Weight gain, metabolic parameters, and the impact of race in aggressive inpatients randomized to double-blind clozapine, olanzapine or haloperidol.

Krakowski M, Czobor P, Citrome L.

Schizophr Res. 2009 May;110(1-3):95-102. doi: 10.1016/j.schres.2009.02.006. Epub 2009 Mar 9.

PMID:
19269139
[PubMed - indexed for MEDLINE]
4.

Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.

Lindenmayer JP, Czobor P, Volavka J, Citrome L, Sheitman B, McEvoy JP, Cooper TB, Chakos M, Lieberman JA.

Am J Psychiatry. 2003 Feb;160(2):290-6.

PMID:
12562575
[PubMed - indexed for MEDLINE]
5.

Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol.

Keefe RS, Seidman LJ, Christensen BK, Hamer RM, Sharma T, Sitskoorn MM, Lewine RR, Yurgelun-Todd DA, Gur RC, Tohen M, Tollefson GD, Sanger TM, Lieberman JA.

Am J Psychiatry. 2004 Jun;161(6):985-95.

PMID:
15169686
[PubMed - indexed for MEDLINE]
6.

A randomized controlled trial of olanzapine versus haloperidol in the treatment of primary negative symptoms and neurocognitive deficits in schizophrenia.

Lindenmayer JP, Khan A, Iskander A, Abad MT, Parker B.

J Clin Psychiatry. 2007 Mar;68(3):368-79.

PMID:
17388705
[PubMed - indexed for MEDLINE]
7.

Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder.

Bilder RM, Goldman RS, Volavka J, Czobor P, Hoptman M, Sheitman B, Lindenmayer JP, Citrome L, McEvoy J, Kunz M, Chakos M, Cooper TB, Horowitz TL, Lieberman JA.

Am J Psychiatry. 2002 Jun;159(6):1018-28.

PMID:
12042192
[PubMed - indexed for MEDLINE]
8.

Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia.

Kinon BJ, Basson BR, Gilmore JA, Tollefson GD.

J Clin Psychiatry. 2001 Feb;62(2):92-100.

PMID:
11247108
[PubMed - indexed for MEDLINE]
9.

A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia.

Meltzer HY, Bobo WV, Roy A, Jayathilake K, Chen Y, Ertugrul A, Anil Yağcioğlu AE, Small JG.

J Clin Psychiatry. 2008 Feb;69(2):274-85.

PMID:
18232726
[PubMed - indexed for MEDLINE]
10.

Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia.

Purdon SE, Jones BD, Stip E, Labelle A, Addington D, David SR, Breier A, Tollefson GD.

Arch Gen Psychiatry. 2000 Mar;57(3):249-58.

PMID:
10711911
[PubMed - indexed for MEDLINE]
11.

The effects of olanzapine on neurocognitive functioning in medication-refractory schizophrenia.

Smith RC, Infante M, Singh A, Khandat A.

Int J Neuropsychopharmacol. 2001 Sep;4(3):239-50.

PMID:
11669086
[PubMed - indexed for MEDLINE]
12.

Effects of atypical antipsychotics on the syndromal profile in treatment-resistant schizophrenia.

Lindenmayer JP, Czobor P, Volavka J, Lieberman JA, Citrome L, Sheitman B, McEvoy JP, Cooper TB, Chakos M.

J Clin Psychiatry. 2004 Apr;65(4):551-6.

PMID:
15119920
[PubMed - indexed for MEDLINE]
13.

Glucose and lipid disturbances after 1 year of antipsychotic treatment in a drug-naïve population.

Perez-Iglesias R, Mata I, Pelayo-Teran JM, Amado JA, Garcia-Unzueta MT, Berja A, Martinez-Garcia O, Vazquez-Barquero JL, Crespo-Facorro B.

Schizophr Res. 2009 Feb;107(2-3):115-21. doi: 10.1016/j.schres.2008.09.028. Epub 2008 Nov 6.

PMID:
18993033
[PubMed - indexed for MEDLINE]
14.

Clozapine enhances neurocognition and clinical symptomatology more than standard neuroleptics.

Potkin SG, Fleming K, Jin Y, Gulasekaram B.

J Clin Psychopharmacol. 2001 Oct;21(5):479-83.

PMID:
11593072
[PubMed - indexed for MEDLINE]
15.

Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.

Volavka J, Czobor P, Sheitman B, Lindenmayer JP, Citrome L, McEvoy JP, Cooper TB, Chakos M, Lieberman JA.

Am J Psychiatry. 2002 Feb;159(2):255-62. Erratum in: Am J Psychiatry 2002 Dec;159(12):2132.

PMID:
11823268
[PubMed - indexed for MEDLINE]
16.

Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.

Krakowski MI, Czobor P, Citrome L, Bark N, Cooper TB.

Arch Gen Psychiatry. 2006 Jun;63(6):622-9.

PMID:
16754835
[PubMed - indexed for MEDLINE]
17.

A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia.

Goff DC, Lamberti JS, Leon AC, Green MF, Miller AL, Patel J, Manschreck T, Freudenreich O, Johnson SA.

Neuropsychopharmacology. 2008 Feb;33(3):465-72. Epub 2007 May 9.

PMID:
17487227
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

[Cognition, schizophrenia and the effect of antipsychotics].

Stip E.

Encephale. 2006 May-Jun;32(3 Pt 1):341-50. Review. French.

PMID:
16840928
[PubMed - indexed for MEDLINE]
19.

Ziprasidone vs clozapine in schizophrenia patients refractory to multiple antipsychotic treatments: the MOZART study.

Sacchetti E, Galluzzo A, Valsecchi P, Romeo F, Gorini B, Warrington L; INITIATE Study Group.

Schizophr Res. 2009 May;110(1-3):80-9. doi: 10.1016/j.schres.2009.02.017. Epub 2009 Mar 9.

PMID:
19269791
[PubMed - indexed for MEDLINE]
20.

Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial.

Harvey PD, Rabinowitz J, Eerdekens M, Davidson M.

Am J Psychiatry. 2005 Oct;162(10):1888-95.

PMID:
16199835
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk